Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies

被引:0
|
作者
Steven L Barriere
Martin E Stryjewski
G Ralph Corey
Fredric C Genter
Ethan Rubinstein
机构
[1] Theravance,Duke Clinical Research Institute and Department of Medicine, Division of Infectious Diseases
[2] Inc,Section of Infectious Diseases, Department of Internal Medicine and Medical Microbiology
[3] Centro de Educación Médica e Investigaciones Clinicas (CEMIC) Norberto Quirno,undefined
[4] Duke University Medical Center,undefined
[5] University of Manitoba,undefined
来源
关键词
Vancomycin; Trough levels; Nosocomial pneumonia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 41 条
  • [1] Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies
    Barriere, Steven L.
    Stryjewski, Martin E.
    Corey, G. Ralph
    Genter, Fredric C.
    Rubinstein, Ethan
    BMC INFECTIOUS DISEASES, 2014, 14
  • [2] The impact of serum vancomycin levels and minimum inhibitory concentrations of methicillin-resistant Staphylococcus aureus on mortality in patients with nosocomial pneumonia
    Machado, Denise Pires
    Goldani, Luciano Z.
    Paiva, Rodrigo Minuto
    Aquino, Valerio Rodrigues
    de-Paris, Fernanda
    Lisboa, Thiago
    Jung, Bruno
    dos Santos, Rodrigo Pires
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2013, 24 (03): : E75 - E79
  • [3] Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis Effectiveness of linezolid in the elderly
    Takada, Hiroaki
    Hifumi, Toru
    Nishimoto, Naoki
    Kanemura, Takashi
    Yoshioka, Hayato
    Okada, Ichiro
    Kiriu, Nobuaki
    Inoue, Junichi
    Koido, Yuichi
    Kato, Hiroshi
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2017, 35 (02): : 245 - 248
  • [4] Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis
    Ping Liu
    Blair Capitano
    Amy Stein
    Ali A. El-Solh
    BMC Nephrology, 18
  • [5] Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis
    Liu, Ping
    Capitano, Blair
    Stein, Amy
    El-Solh, Ali A.
    BMC NEPHROLOGY, 2017, 18
  • [6] The association of vancomycin trough levels with outcomes among patients with methicillin-resistant Staphylococcus aureus (MRSA) infections: Retrospective cohort study
    Yahav, Dafna
    Abbas, Maria
    Nassar, Laila
    Ghrayeb, Alia
    Kurnik, Daniel
    Shepshelovich, Daniel
    Leibovici, Leonard
    Paul, Mical
    PLOS ONE, 2019, 14 (04):
  • [7] Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies
    Prybylski, John P.
    PHARMACOTHERAPY, 2015, 35 (10): : 889 - 898
  • [8] Linezolid vs vancomycin -: Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia
    Wunderink, RG
    Rello, J
    Cammarata, SK
    Croos-Dabrera, RV
    Kollef, MH
    CHEST, 2003, 124 (05) : 1789 - 1797
  • [9] Economic evaluation among Chinese patients with nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus and treated with linezolid or vancomycin: a secondary, post-hoc analysis based on a Phase 4 clinical trial study
    Wan, Yin
    Li, Qiang
    Chen, Yixi
    Haider, Seema
    Liu, Sizhu
    Gao, Xin
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (01) : 53 - 62
  • [10] Iron serum levels and iron homeostasis parameters in patients with nosocomial pneumonia treated with cefiderocol: post hoc analysis of the APEKS-NP study
    Eric P. Skaar
    Roger Echols
    Yuko Matsunaga
    Anju Menon
    Simon Portsmouth
    European Journal of Clinical Microbiology & Infectious Diseases, 2022, 41 : 467 - 476